Platinum-resistant Ovarian Cancer (PROC)
7 clinical trials · Condition
◉ Watch Platinum-resistant Ovarian Cancer (PROC)
| Record | Firm | Date |
|---|---|---|
| A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors (NCT03311334) | Sumitomo Pharma America, Inc. | 2017-12-14 |
Track Platinum-resistant Ovarian Cancer (PROC) automatically
Every clearance here is in the API, with alerts when new ones post.